Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.8350 (-3.46%) ($6.8350 - $6.8350) on Thu. Jul. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.01% (three month average) | RSI | 21 | Latest Price | $6.8350(-3.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.7% a day on average for past five trading days. | Weekly Trend | CGEN declines -7.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(72%) ARKG(70%) ARKK(67%) IWO(66%) ACES(63%) | Factors Impacting CGEN price | CGEN will decline at least -2.005% in a week (0% probabilities). VIXM(-49%) VXX(-38%) UUP(-16%) TLT(-8%) IGOV(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.005% (StdDev 4.01%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.11(-160.13%) | Resistance Level | $7.84 | 5 Day Moving Average | $7.34(-6.88%) | 10 Day Moving Average | $7.53(-9.23%) | 20 Day Moving Average | $7.84(-12.82%) | To recent high | -24.7% | To recent low | 0% | Market Cap | $565m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |